Business
CB2 Insights Announces Upsize to Bought Deal Public Offering to C$5m
CB2 Insights Announces Upsize to Bought Deal Public Offering to C$5m.
About this update from Skylight Health Group Inc.
[{"type":"text","content":"\n\n\n\nCB2 Insights Announces Upsize to Bought Deal Public Offering to C$5m\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nCB2 Insights Announces Upsize to Bought Deal Public Offering to C$5m\nCanada NewsWire\nTORONTO, Oct. 29, 2020\n\n\n\n /NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/\n TORONTO, Oct. 29, 2020 /CNW/ - CB2 Insights (CSE:CBII) (OTCQB: CBIIF) (\"CB2\" or the \"Company\") is pleased to announce that it has amended the terms of its previously announced offering of Common Shares (as defined below). Under the amended terms of the Offering (as defined below) a syndicate of underwriters (the \"Underwriters\") co-led by Echelon Capital Markets (\"Echelon\") and Beacon Securities Limited, and including Canaccord Genuity Corp., Mackie Research Capital Corp., Leede Jones Gable Inc. and PI Financial Corp., and pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 10,640,000 common shares (the \"Common Shares\", each a \"Common Share\") in the capital of the Company at a price of C$0.47 per Common Share (the \"Offering Price\") for aggregate gross proceeds to the Company of C$5,000,800 (the \"Offering\").\nThe Company has granted the Underwriters an option to purchase up to an additional 15% of the Common Shares sold under the Offering, at the Issue Price. The Over-Allotment Option may be exercised in whole or in part to purchase Common Shares as determined by the Underwriters upon written notice to the Company at any time up to 30 days following the closing date of the Offering (the \"Over-Allotment Option\").\nCB2 Insights intends to use the proceeds of the Offering for strategic M&A activities and general corporate purposes.\nThe Offering will be completed (i) by way of a short form prospectus to be filed in Alberta, British Columbia, Manitoba and Ontario, (ii) on a private placement basis in the United States pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the \"U.S. Securities...